 | - August 9, 2022
- August 2022 Article Summary: Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial, The Lancet Rheumatology, Volume 3, Issue 7, 2021, Pages e489-e497, ISSN 2665-9913, https://doi.org/10.1016/S2665-9913(21)00107-7. View here.
- Recorded Zoom Webinar on VuMedi.
|
| | - July 12-13, 2022
- July 2022 Article Summary: The impact of disease severity measures on survival in U.S. Veterans with rheumatoid arthritis-associated interstitial lung disease, Rheumatology, 2022, keac208, https://doi.org/10.1093/rheumatology/keac208. View here.
- Recorded Zoom Webinar on VuMedi.
|
| | - June 14-15, 2022
- June 2022 Article Summary: Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. N Engl J Med. 2022 May 15. doi: 10.1056/NEJMoa2201737. Epub ahead of print. PMID: 35569036. View here.
- Recorded Zoom Webinar on VuMedi.
|
| | - May 10-11, 2022
- May 2022 Article Summary: The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work Group, Chest, 2022, ISSN 0012-3692, https://doi.org/10.1016/j.chest.2022.03.023. View here.
- Recorded Zoom Webinar on VuMedi.
|
| - April 19-20, 2022
- April 2022 Article Summary: Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease. Respir Med. 2019 Jul-Aug;154:6-11. doi: 10.1016/j.rmed.2019.05.012. Epub 2019 May 21. PMID: 31176796. View here.
- Recorded Zoom Webinar on VuMedi.
|
| - March 8-9, 2022
- March 2022 Article Summary: Diagnostic Accuracy of Endobronchial Optical Coherence Tomography for the Microscopic Diagnosis of Usual Interstitial Pneumonia. Am J Respir Crit Care Med. 2021 Nov 15;204(10):1164-1179. doi: 10.1164/rccm.202104-0847OC. PMID: 34375171. View here.
- Recorded Zoom Webinar on VuMedi.
|
| - February 8-9, 2022
- February 2022 Article Summary: Leukocyte Telomere Length and Mycophenolate Therapy in Chronic Hypersensitivity Pneumonitis. Eur Respir J. 2021 Mar 4;57(3):2002872. doi: 10.1183/13993003.02872-2020. Print 2021 Mar. View here.
- Recorded Zoom Webinar on VuMedi.
|
| - December 14-15, 2021
- December 2021 Article Summary: Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med 2019; 381:1718-1727 DOI: 10.1056/NEJMoa1908681. View here.
- Recorded Zoom Webinar on VuMedi.
|
| - November 9-10, 2021
- November 2021 Article Summary: Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med 2021;384:599-609. DOI: 10.1056/NEJMoa2023386. View here.
- Recorded Zoom Webinar on VuMedi.
|
| - October 12-13, 2021
- October 2021 Article Summary: Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia. Am J Respir Crit Care Med. 2021 Jan 15;203(2):211-220. doi: 10.1164/rccm.202003-0877OC. View here.
- Recorded Zoom Webinar on VuMedi.
|
| - September 14, 2021
- September 2021 Article Summary: Tocilizumab in systemic sclerosis: a randomized, double-blind, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. View here.
- Recorded Zoom Webinar on VuMedi.
|
| - August 10-11, 2021
- August 2021 Article Summary: Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomized controlled trial, The Lancet Respiratory Medicine. 2018;6(10):759-770. View here.
- Recorded Zoom Webinar on VuMedi.
|
